Saluting Self-Testers

Saluting Self-Testers I found the article "Heal Thyself or Die Trying"1 particularly interesting because my father, Richard K. Bernstein, MD, developed blood glucose while self-monitoring for diabetes almost 30 years ago. A Type-1 diabetic from age 12, Dr. Bernstein was beginning to suffer from diabetic complications in his 30's. Using a cumbersome, first-generation blood glucose monitoring device available only to hospital emergency rooms (to distinguish comatose diabetics from drunks), h

Written byJulie Bernstein
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

I found the article "Heal Thyself or Die Trying"1 particularly interesting because my father, Richard K. Bernstein, MD, developed blood glucose while self-monitoring for diabetes almost 30 years ago. A Type-1 diabetic from age 12, Dr. Bernstein was beginning to suffer from diabetic complications in his 30's. Using a cumbersome, first-generation blood glucose monitoring device available only to hospital emergency rooms (to distinguish comatose diabetics from drunks), he learned to control his diabetes by appropriately titering his insulin and adjusting his diet. Although successful small-scale trials of his methods were conducted at New York's Rockefeller University, physicians remained reluctant to promote my father's approaches, which included adherence to a high protein/low carbohydrate diet and multiple small doses of insulin daily. Diabetologists feared the possibility of hypoglycemia (low blood sugars) in patients attempting to maintain normal blood sugars.

At age 45, my father left successful careers in biomedical engineering and management ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies